Salem, CT, United States of America

David Christopher Limburg

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Contributions of David Christopher Limburg

Introduction

David Christopher Limburg is a notable inventor based in Salem, Connecticut, who has made significant contributions to the field of pharmaceutical sciences. With a total of seven patents to his name, Limburg's work focuses on developing compounds that address critical health issues.

Latest Patents

One of Limburg's latest patents is titled "Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors." This invention relates to boron-containing compounds that inhibit phosphodiesterase 4 (PDE4). The patent also encompasses pharmaceutical compositions containing these compounds and methods for treating diseases, conditions, or disorders that can be ameliorated by the inhibition of PDE4. Another significant patent is "Bicyclic heteroaryl derivatives as CFTR potentiators." This invention involves 5,7-disubstituted-imidazo[5,1-f][1,2,4]triazine-4-amine derivatives, which are potentiators of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR). The patent details pharmaceutical compositions comprising these compounds, which are useful for treating cystic fibrosis, asthma, chronic obstructive pulmonary disease, and other CFTR-associated disorders.

Career Highlights

Throughout his career, Limburg has worked with prominent organizations such as Cystic Fibrosis Foundation Therapeutics, Inc. and the Cystic Fibrosis Foundation. His innovative work has contributed to advancements in treatments for various respiratory and metabolic conditions.

Collaborations

Limburg has collaborated with notable professionals in his field, including Joseph Walter Strohbach and John Paul Mathias. These collaborations have further enhanced the impact of his inventions.

Conclusion

David Christopher Limburg's contributions to pharmaceutical innovation demonstrate his commitment to improving health outcomes through scientific research and development. His patents reflect a dedication to addressing complex medical challenges, making him a significant figure in the field of invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…